Displaying drugs 1026 - 1050 of 2779 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Ferumoxsil | Not Annotated |  | Not Annotated | Superparamagnetic Contrast Media |
| Ferumoxytol | 231.531 Fe3O4 |  | An intravenous iron replacement product used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), or in patients who are unable to tolerate or who have not responded adequately to oral iron supplementation. | Ferric Compounds / Ferrous Compounds / Hematinics / Minerals / Paramagnetic Contrast Agent / Parenteral Iron Replacement / Parenteral Nutrition Solutions |
| Fesoterodine | 411.5769 C26H37NO3 |  | An antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. | Drugs for Urinary Frequency and Incontinence |
| Fexinidazole | 279.31 C12H13N3O3S |  | An orally bioavailable 2-substituted 5-nitroimidazole used to treat early- and late-stage human African trypanosomiasis caused by Trypanosoma brucei gambiense. | Nitroimidazole Derivatives |
| Fexofenadine | 501.6564 C32H39NO4 |  | A selective H1-antagonist for the symptomatic treatment of seasonal allergic rhinitis and chronic idiopathic urticaria. | Anti-Allergic Agents / Histamine H1 Antagonists / Histamine H1 Antagonists, Non-Sedating |
| Fezolinetant | 358.4 C16H15FN6OS |  | A non-hormonal drug used to treat moderate to severe vasomotor symptoms due to menopause. | Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 Substrates / Genito Urinary System and Sex Hormones / Heterocyclic Compounds, Fused-Ring / Neurokinin 3 Receptor Antagonist / Sulfur Compounds / Thiazoles |
| Fidaxomicin | 1058.05 C52H74Cl2O18 |  | A macrolide antibiotic used to treat diarrhea associated with Clostridium difficile infection. | Anti-Bacterial Agents |
| Filgotinib | 425.51 C21H23N5O3S |  | A Janus kinase (JAK) 1 selective inhibitor used to treat cases of rheumatoid arthritis that are unresponsive to conventional treatments. | Selective Immunosuppressants |
| Finafloxacin | 398.394 C20H19FN4O4 |  | Finafloxacin is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus in patients age 1... | Anti-Bacterial Agents / Anti-Infective Agents, Urinary / Quinolone Antimicrobial / Topoisomerase II Inhibitors |
| Finasteride | 372.5441 C23H36N2O2 |  | An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase. | Adrenergic alpha-Antagonists |
| Finerenone | 378.432 C21H22N4O3 |  | A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. | Nonsteroidal Mineralocorticoid-Receptor Antagonist |
| Fingolimod | 307.4708 C19H33NO2 |  | A sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19. | Selective Immunosuppressants |
| Flavin adenine dinucleotide | 785.5497 C27H33N9O15P2 |  | A coenzyme form of vitamin B2 used in clinical conditions associated with vitamin B2 deficiency. | Adenine Nucleotides / Vitamin B Complex |
| Flavin mononucleotide | 456.3438 C17H21N4O9P |  | A form of vitamin B2 used to restore riboflavin in anemia, migraine, alcoholism, and hyperhomocysteinemia. | Ribonucleotides / Vitamin B Complex |
| Flavone | 222.2387 C15H10O2 |  | Not Available | Flavones |
| Flavoxate | 391.4596 C24H25NO4 |  | A muscarinic antagonist and spasmolytic used for the symptomatic relief of conditions associated with lack of muscle control in the bladder, such as dysuria, urgency, and nocturia. | Drugs for Urinary Frequency and Incontinence |
| Flecainide | 414.3427 C17H20F6N2O3 |  | A class Ic antiarrhythmic agent used to manage atrial fibrillation and paroxysmal supraventricular tachycardias (PSVT). | Antiarrhythmic agents / Antiarrhythmics, Class Ic / Piperidines / Voltage-Gated Sodium Channel Blockers |
| Flibanserin | 390.4021 C20H21F3N4O |  | A 5-HT receptor modulator used for the treatment of selected premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). | Agents that produce hypertension |
| Floctafenine | 406.3552 C20H17F3N2O4 |  | An anti-inflammatory analgesic used to manage mild to moderate acute pain. | Agents that produce hypertension |
| Florbetaben F-18 | 358.444 C21H26FNO3 |  | A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment. | Fluorine Radioisotopes / Radioactive Diagnostic Agent |
| Florbetapir (18F) | 359.432 C20H25FN2O3 |  | A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment. | Fluorine Radioisotopes / Radioactive Diagnostic Agent |
| Flortaucipir F-18 | 262.278 C16H10FN3 |  | A small lipophilic tracer containing [18F]fluoride capable of crossing the blood-brain barrier and binding to aggregated tau protein; used in PET imaging for the diagnosis of Alzheimer's disease. | Contrast Media |
| Flosequinan | 239.26 C11H10FNO2S |  | Flosequinan was approved in the USA and the UK for a year prior to being withdrawn from the market due to increased mortality in chronic heart failure patients, found in... | Quinolone Vasodilators |
| Flotufolastat F-18 | 1470.63 C63H99FN12O25Si |  | A radiopharmaceutical diagnostic agent used in PET imaging to visualize PSMA-positive lesions in men with prostate cancer with suspected metastasis or recurrence. | Diagnostic Radiopharmaceuticals / Fluorine Radioisotopes / Positron Emitting Activity / Radioactive Diagnostic Agent |
| Floxuridine | 246.1924 C9H11FN2O5 |  | An antimetabolite used as palliative management for liver metastases of gastrointestinal malignancy. | Pyrimidine Analogues |
Displaying drugs 1026 - 1050 of 2779 in total